SEC Form 4/A · accession 0001209191-18-001224
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Richard A Lerner
Director
Period of report
Dec 29, 2017
Accepted (ET)
Jan 3, 2018 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 29, 2017 | A | 949 | $14.48 | A | 9,570 | D | |
| Common StockF1 | holding | — | — | — | 53,000 | I | Held by the Lerner Family Trust UAD 11/14/94 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
Remarks
This amendment to Form 4 is filed solely to reflect that the correct Transaction Code for the reported transaction is "A".